Stay updated on GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page
- Check3 days agoChange DetectedNo textual changes were detected on the page; the study details and related information remain as published. The overall presentation and structure appear unchanged.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6 on the page, indicating a minor template/system update that does not alter the study data.SummaryDifference0.2%

- Check17 days agoChange DetectedAdds a funding note '2017 ( U.S. NIH Grant/Contract )' to the study record, providing context about the study's funding. This contextualizes the source of support for the trial.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.6.5 was added, replacing the previous v3.6.4. This change represents an update to the page's metadata rather than substantive alterations to the study details or participant information.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a new site revision.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision: v3.6.3 has been added, replacing Revision: v3.6.2. This indicates a minor update to the study record page.SummaryDifference0.2%

Stay in the know with updates to GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.